Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03980457 · ClinicalTrials.gov registry record · NA

Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke

A NA study of Stroke and Weakness of Extremities as Sequela of Stroke, sponsored by University of Oklahoma.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT03980457 is a NA study of Stroke and Weakness of Extremities as Sequela of Stroke that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 50 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03980457, a NA study of Stroke and Weakness of Extremities as Sequela of Stroke, is actively recruiting participants, sponsored by University of Oklahoma.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to determine the efficacy of electromechanical exoskeleton-assisted gait training on rehabilitation functional outcomes in patients with stroke undergoing therapy in an in-patient rehabilitation facility.

Interventions

  • DEVICE Indego Exoskeleton
  • OTHER Standard Rehabilitation

Study Locations (1)

Oklahoma

  • Oklahoma City VA Health Care System - Oklahoma City

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2021-09-01
Est. Completion 2028-09-01
Phase NA

Sponsor

University of Oklahoma

358 total trials

What the Registry Record Tells You About NCT03980457

The ClinicalTrials.gov registry entry for NCT03980457 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Indego Exoskeleton is the first listed.

NCT03980457 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.

Frequently Asked Questions

What is clinical trial NCT03980457 about?

NCT03980457 is a clinical study titled "Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke". The goal of this study is to determine the efficacy of electromechanical exoskeleton-assisted gait training on rehabilitation functional outcomes in patients with stroke undergoing therapy in an in-patient rehabilitation facility.

What is the current status of trial NCT03980457?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2021-09-01. Estimated completion is 2028-09-01.

What conditions does trial NCT03980457 study?

This clinical trial studies the following conditions: Stroke, Weakness of Extremities as Sequela of Stroke.

What interventions are being tested in trial NCT03980457?

The interventions under investigation include: Indego Exoskeleton (DEVICE), Standard Rehabilitation (OTHER).

Who is sponsoring clinical trial NCT03980457?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03980457 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.